Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
The process of stool transfer from healthy donors to the sick, known as faecal microbiota transplantation (FMT), has an ancient history. However, only recently researchers started investigating its applications in an evidence-based manner. Current knowledge of the microbiome, the concept of dysbiosis and results of preliminary research suggest that there is an association between gastrointestinal bacterial disruption and certain disorders. Researchers have studied the effects of FMT on various gastrointestinal and non-gastrointestinal diseases, but have been unable to precisely pinpoint specific bacterial strains responsible for the observed clinical improvement or futility of the process. The strongest available data support the efficacy of FMT in the treatment of recurrent Clostridium difficile infection with cure rates reported as high as 90% in clinical trials. The use of FMT in other conditions including inflammatory bowel disease, functional gastrointestinal disorders, obesity and metabolic syndrome is still controversial. Results from clinical studies are conflicting, which reflects the gap in our knowledge of the microbiome composition and function, and highlights the need for a more defined and personalised microbial isolation and transfer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Data suggest that the gut microbiota plays an underlying role in several stress-associated neuropsychological conditions, including anxiety and depressive disorders [58][59][60].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“obese mice exhibited a significantly greater percentage increase in body fat over a short period of time.(70) Ridaura et al(71) showed that germ-free mice inoculated”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“ition and metabolic function of the gut microbiota of obese participants.(68) 69 The exact mechanisms by which ‘obese microbiota’”
BackgroundGut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182 · cited 1×
“’.(1) Faecal transfer from healthy donors to the sick in order to treat disease has been described in the ancient medical literature.”
BackgroundGut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“However, the SCFAs production was greater in lean mice compared with obese mice, suggesting that increased weight gain is not simply a result of increased energy harvest, but rather from SCFAs promoting leanness by inhibiting fat accumulation in adipose tissue, raising energy expenditure, and enhancing the production…”
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913 · cited 1×
“Recently, a double-blind, randomised controlled trial on participants with metabolic syndrome demonstrated that FMT from lean to obese participants resulted in improvement in peripheral insulin sensitivity and significant increase in gut microbial diversity.(77) To date, there are no clinical trials to assess the effe…”
BackgroundThe functional gastrointestinal disorders and the Rome III process
Drossman, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.008 · Cited by 2,416 · cited 1×
“FMT IN THE MANAGEMENT OF FUNCTIONAL GI DISORDERS Functional GI disorders (FGIDs) are a group of disorders characterised by a constellation of symptoms that are not explained by other pathologically based disorders.(45) Irritable bowel syndrome (IBS) is the most prevalent FGID, accounting for 10–20% of the population i…”
BackgroundGlobal Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155 · cited 1×
“45 Irritable bowel syndrome (IBS) is the most prevalent FGID, accounting for 10 – 20% of the population in developed countries 46 – 48 and has a profound effect on the quality of life and healthcare expenditure.”
Background
Research works printed but not linked: 1
- Borody T , Leis S , McGrath K , et al . Treatment of chronic constipation and colitis using human probiotic infusions. Probiotics, Prebiotics and New Foods Conference ; 2–4 September 2001; Rome: Universita Urbaniana, 2001.
Cited by
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential
Saus, E., Iraola-Guzmán, S., Willis, J. R., Brunet-Vega, A., & Gabaldón, T. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.05.001 · Cited by 350
Rebuilding the Gut Microbiota Ecosystem
Gagliardi, A., Totino, V., Cacciotti, F., Iebba, V., Neroni, B., Bonfiglio, G., Trancassini, M., Passariello, C., Pantanella, F., & Schippa, S. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081679 · Cited by 340
“Microbiota rebalanced by well-defined microbial communities comprising gut bacteria could represent an alternative to FMT [164] (see paragraph: Bacterial consortium transplantation).”
BackgroundMocanu, V., Zhang, Z., Deehan, E. C., Kao, D. H., Hotte, N., Karmali, S., Birch, D. W., Samarasinghe, K. K., Walter, J., & Madsen, K. L. (2021) · Nature Medicine · doi:10.1038/s41591-021-01399-2 · Cited by 328
Legrand, T. P. R. A., Wynne, J. W., Weyrich, L. S., & Oxley, A. P. A. (2020) · Reviews in Aquaculture · doi:10.1111/raq.12375 · Cited by 265
Metadata
- Authors
- Sbahi, H., & Di Palma, J. A.
- Affiliations
- University of South Alabama (US)
- Division of Gastroenterology, University of South Alabama College of Medicine, Mobile, Alabama, USA
- Venue
- BMJ Open Gastroenterology
- Publisher
- BMJ
- Published
- 2016-05
- Volume
- 3
- Issue
- 1
- Pages
- e000087
- ISSN
- 2054-4774 (ISSN-L)
- PMC
- PMC4873946
- OpenAlex
- W2346413605
- Cited by
- 75
- References
- 90
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 8 · 2023: 4 · 2022: 10 · 2021: 15 · 2020: 10 · 2019: 6 · 2018: 5 · 2017: 3 · 2016: 3
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open Gastroenterology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, gut microbiota, dysbiosis, Clostridium difficile infection, inflammatory bowel disease, functional gastrointestinal disorders, obesity, metabolic syndrome, donor selection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. https://app.cochat.ai/papers/10.1136/bmjgast-2016-000087
- The paper
- Sbahi, H., & Di Palma, J. A. (2016). Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterology. https://doi.org/10.1136/bmjgast-2016-000087
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.